Advertisement Navigenics names new president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Navigenics names new president and CEO

Navigenics, a personal genomics testing company, has appointed Jonathan Lord as its new president and CEO, effective May 1, 2009.

Dr Lord comes to Navigenics from Louisville, Kentucky-based Humana, where as chief innovation officer he was responsible for designing new products and services to enable people to navigate the healthcare system and support their health needs.

Before Humana, Dr Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care. Dr Lord also serves on the board of Stericycle, a provider of healthcare infection control and compliance services, and Dexcom, a developer of glucose monitoring systems.

Dana Mead, Jr, member of board of directors at Navigenics, said: “Jack has a unique, 360-degree understanding of the healthcare ecosystem and will no doubt help lead the entire genomics industry as genetic science, clinical adoption and public policy evolve.”